Dexcel Pharma is a pharmaceutical company engaged in the discovery, development, manufacture, and commercialization of innovative pharmaceutical products based on its proprietary controlled-release technologies. Dexcel Pharma develops novel formulations of existing molecules for large therapeutic markets. The companys aim is to provide meaningful clinical benefits for patients with chronic diseases. For example, the companys PerioChip product offers a new approach to treating gum disease by using a small chip inserted under the gums. Dexcel Pharmas development pipeline includes more than 30 novel 505(b)2 formulations and complex generics, targeting markets in the U.S. and the EU.